BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19948346)

  • 21. Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route.
    Kang X; Huang S; Yang P; Ma P; Yang D; Lin J
    Dalton Trans; 2011 Mar; 40(9):1873-9. PubMed ID: 21183970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and controlled release of mesoporous MCM-41/propranolol hydrochloride composite drug.
    Zhai QZ
    J Microencapsul; 2013; 30(2):173-80. PubMed ID: 22894165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained release of heparin on enlarged-pore and functionalized MCM-41.
    Wan MM; Yang JY; Qiu Y; Zhou Y; Guan CX; Hou Q; Lin WG; Zhu JH
    ACS Appl Mater Interfaces; 2012 Aug; 4(8):4113-22. PubMed ID: 22850329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-Trp adsorption into silica mesoporous materials to promote bone formation.
    Balas F; Manzano M; Colilla M; Vallet-Regí M
    Acta Biomater; 2008 May; 4(3):514-22. PubMed ID: 18234569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photoactive hybrid nanomaterials: indocyanine immobilized in mesoporous MCM-41 for "in-cell" bioimaging.
    Gianotti E; Bertolino CA; Benzi C; Nicotra G; Caputo G; Castino R; Isidoro C; Coluccia S
    ACS Appl Mater Interfaces; 2009 Mar; 1(3):678-87. PubMed ID: 20355990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chemical modification on carbon dioxide adsorption property of mesoporous silica.
    Zhao Y; Shen Y; Bai L
    J Colloid Interface Sci; 2012 Aug; 379(1):94-100. PubMed ID: 22621911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
    Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
    J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of CO in mesoporous silica monitored by time-resolved step-scan and rapid-scan FT-IR spectroscopy.
    Andersen LK; Frei H
    J Phys Chem B; 2006 Nov; 110(45):22601-7. PubMed ID: 17092007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of antimicrobial compounds in mesoporous silica film monolith.
    Izquierdo-Barba I; Vallet-Regí M; Kupferschmidt N; Terasaki O; Schmidtchen A; Malmsten M
    Biomaterials; 2009 Oct; 30(29):5729-36. PubMed ID: 19628277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of 2-mercaptobenzothiazole-derivatized mesoporous silica and removal of Hg(ii) from aqueous solution.
    Pérez-Quintanilla D; Del Hierro I; Fajardo M; Sierra I
    J Environ Monit; 2006 Jan; 8(1):214-22. PubMed ID: 16395482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and evaluation of aminopropyl-functionalized manganese-loaded SBA-15 for copper removal from aqueous solution.
    Lei D; Zheng Q; Wang Y; Wang H
    J Environ Sci (China); 2015 Feb; 28():118-27. PubMed ID: 25662246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
    Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
    Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
    Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
    Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
    Song SW; Hidajat K; Kawi S
    Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of rice husk ash as silica source for the synthesis of mesoporous silicas and their application to CO2 adsorption through TREN/TEPA grafting.
    Bhagiyalakshmi M; Yun LJ; Anuradha R; Jang HT
    J Hazard Mater; 2010 Mar; 175(1-3):928-38. PubMed ID: 19939554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
    Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, characterization, and Zn(2+) adsorption behavior of chemically modified MCM-41 with 5-mercapto-1-methyltetrazole.
    Pérez-Quintanilla D; Sánchez A; del Hierro I; Fajardo M; Sierra I
    J Colloid Interface Sci; 2007 Sep; 313(2):551-62. PubMed ID: 17532331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminopropyl-modified mesoporous silica SBA-15 as recovery agents of Cu(II)-sulfate solutions: Adsorption efficiency, functional stability and reusability aspects.
    Lombardo MV; Videla M; Calvo A; Requejo FG; Soler-Illia GJ
    J Hazard Mater; 2012 Jul; 223-224():53-62. PubMed ID: 22595542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesoporous silicate MCM-41 as a particulate carrier for octyl methoxycinnamate: Sunscreen release and photostability.
    Ambrogi V; Latterini L; Marmottini F; Pagano C; Ricci M
    J Pharm Sci; 2013 May; 102(5):1468-75. PubMed ID: 23459857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.